Somewhat counterintuitively to frequentists, this is not a problem if they did Bayesian analysis. Many new trails for COVID19 therapeutics are actually reporti

Somewhat counterintuitively to frequentists, this is not a problem if they did Bayesian analysis. Many new trails for COVID19 therapeutics are actually reporting realtime Bayesian estimates of efficacy. https://www.pwc.com/us/en/industries/health-industries/library/coronavirus-who-master-clinical-protocol.html https://www.pwc.com/us/en/industries/health-industries/libra...